The DVO Report

Physician Newsletter Archive

July 2014 – Updated Cancer Screening Guidelines

Dr. Tiffany Svahn discussing the updates to cancer screening guidelines.

June 2014 – Prostate Cancer Treatment Utilizes ‘GPS’ Technology

Dr. Sophia Rahman discussing the Calypso 4D localization system and the technology’s potential to improve patient outcomes.

April 2014 – HPV and Head & Neck Cancer

Dr. Matthew Sirott focuses on statistics of head and neck cancer, as well as the new risk factor of human
papillomavirus (HPV).

March 2014 – Highlights of the San Antonio Breast Cancer Symposium

Dr. Tiffany Svahn focuses on new data that was presented at the Breast Cancer Symposium that may potentially change the way providers treat breast cancer.

December 2013 – Issues With the Newer Oral Anticoagulants

Dr. Robert Robles focuses on issues with recently approved Oral Anticoagulants in treatments for deep venous thrombosis or pulmonary embolus.

November 2013 – Lung Cancer Screening

In the November physician newsletter, Dr. Gigi Chen discussed updates on Lung Cancer screening and the need for an effective screening modality for the cancer type given advances in treatment for advanced Lung Cancer.

October 2013 – Breast Cancer Radiation in the Modern Era: Intraoperative Radiation Therapy

In the October physician newsletter, Dr. Rahman discussed breast cancer radiation in the modern era including the paradigm of early-stage breast cancer management shifting from radical mastectomy to breast conservation therapy.

June 2012 – Cancer Update 2012

Cancer update 2012 by Dr. Chen discusses exciting abstracts presented at this year’s American Society of Clinical Oncology annual meeting in Chicago in June

February 2012 – What is Prop 29?

Dr. Sirott on Prop 29 (California Cancer Research Act). DVO is the major backer in Central Contra Costa County, in coordination with American Cancer Society

January 2012 – Updates from ASH

Dr. Robles discusses the American Society of Hematology (ASH) meeting that included high profile science presentations & clinical trials.